New study highlights potential for cost effective NHS policy
New research at West Virginia University is examining whether a smokeless, spitless tobacco product aimed at young adults is catching on. And the researchers have found that RJ Reynolds’ Camel Snus - touted as a socially acceptable way to satisfy addiction - contains surprisingly high levels of nicotine. “Camel Snus contains more nicotine than most
Full Post: Tobacco companies trying to market new smokeless, spitless tobacco products to young adults
A new University of Leicester study reveals that screening people who are at risk of developing diabetes could be a cost-effective health policy and improve the lives of patients.
In her inaugural lecture on Wednesday 12th November, Dr Clare Gillies of the Department of Health Sciences will reveal the results of her simulation study investigating the clinical and cost implications of screening people ‘at risk’ for impaired glucose intolerance and type 2 diabetes mellitus.
An important outcome of the work by Dr Gillies shows that early treatment and intervention resulting from this screening is potentially a cost-effective health policy for the UK.
Dr. Gillies is the winner of the School of Medicine Lauder Prize for best PhD. The prize will be awarded at the end of her lecture which starts at 5.30pm in the Frank and Katherine May lecture theatre, Henry Wellcome Building.
Her research involved comparing the cost and health implications of four different approaches to screening for impaired glucose tolerance and type 2 diabetes. These were:
i) no screening
ii) screening for type 2 diabetes alone resulting in health benefits from early diagnosis and treatment of the disease
iii) screening for impaired glucose tolerance and type 2 diabetes, allowing for both early treatment of diabetes and for lifestyle interventions to be applied to individuals with impaired glucose tolerance to reduce their risk of developing diabetes
iv) as for iii) but with pharmacological rather than lifestyle interventions
Dr Gillies developed a computer decision model using data from a number of sources to evaluate the cost and health implications of these four policies.
She said: “The model simulated a population with an increased risk of developing type 2 diabetes, who were aged 45 at the start of the model and thus time of screening. The model was run to estimate the cost and health implications over a 50 year time horizon, and the four different screening policies were then compared.
“Conclusions drawn from the work were that screening for type 2 diabetes and impaired glucose tolerance, with appropriate interventions for the latter, in an above average risk population at age 45, appears to be cost effective.
“The cost effectiveness of a policy of screening for diabetes alone, which offered no intervention to those with impaired glucose tolerance, is still uncertain and more information is needed on the long term health implications of early diagnosis and treatment of this disease.”
The work was funded jointly by the Economic and Social Research Council (ESRC) and the Medical Research Council (MRC) as part of an interdisciplinary research initiative in the social and medical sciences.
Dr Clare Gillies is a medical statistician who has been based at the University of Leicester for 8 years, after gaining an MSc in medical statistics from the London School of Hygiene and Tropical Medicine in 2000. During this time she has worked on a number of projects including a Ph.D. investigating evidence synthesis methods for health policy decision making, with particular reference to policies concerning screening for type 2 diabetes mellitus. She joined the Ehleis project (European Health and Life Expectancy Information Systems) in 2007 and will be working on identifying factors associated with inequalities in healthy life years across EU member states, using a variety of datasets.
Dr. Clare Gillies is the winner of the School of Medicine Lauder Prize for best PhD. The prize will be awarded at the end of her lecture.
A third of Americans with diabetes do not know that they have it, and many more who have prediabetic conditions are unaware that they are at risk. A University of Missouri researcher has created a clinical tool to identify those at highest risk for having undetected hyperglycemia, impaired fasting glucose (IFG) and undiagnosed diabetes. If
Full Post: New clinical tool to identify those at highest risk for having undetected hyperglycemia
A study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine suggests that screening type 2 diabetes patients for obstructive sleep apnea (OSA) and treating those who have OSA with continuous positive airway pressure (CPAP) therapy could improve the management of their hyperglycemia and might favorably influence their long-term prognosis. Results
Full Post: Continuous positive airway pressure improves sleeping glucose levels in type 2 diabetics with obstructive sleep apnea
Solianis has just finalised a test series in which patients with diabetes have worn the first configuration of the multisensor system for non-invasive Continuous Glucose Monitoring at home and at work. Results show that the system tracks glucose in these settings and that it is sensitive to hyper- and hypoglycemic glucose excursions. “This is the
Full Post: Non-invasive glucose monitoring system
According to new research from the U.S. eating too many eggs may increase the risk of a person developing type 2 diabetes - and this applies to both men and women. The researchers from Brigham and Women’s Hospital and Harvard Medical School examined data from two completed randomized trials - the Physicians’ Health Study I
Full Post: Eating too many eggs may raise your risk of type 2 diabetes
A study published by the Journal of the American Medical Association (JAMA ) on 16 December 2008 has found that those with type 2 diabetes who had a diet high in low-glycemic foods such as nuts, beans and lentils had greater improvement in glycemic control and risk factors for coronary heart disease than those on
Full Post: Well balanced diet improves blood glucose tolerance and blood lipid levels